Aspirin Inhibits Colon Cancer Cell and Tumor Growth and Downregulates Specificity Protein (Sp) Transcription Factors
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Acetylsalicylic acid (aspirin) is highly effective for treating colon cancer patients postdiagnosis; however, the mechanisms of action of aspirin in colon cancer are not well defined. Aspirin and its major metabolite sodium salicylate induced apoptosis and decreased colon cancer cell growth and the sodium salt of aspirin also inhibited tumor growth in an athymic nude mouse xenograft model. Colon cancer cell growth inhibition was accompanied by downregulation of Sp1, Sp3 and Sp4 proteins and decreased expression of Sp-regulated gene products including bcl-2, survivin, VEGF, VEGFR1, cyclin D1, c-MET and p65 (NFκB). Moreover, we also showed by RNA interference that β-catenin, an important target of aspirin in some studies, is an Sp-regulated gene. Aspirin induced nuclear caspase-dependent cleavage of Sp1, Sp3 and Sp4 proteins and this response was related to sequestration of zinc ions since addition of zinc sulfate blocked aspirin-mediated apoptosis and repression of Sp proteins. The results demonstrate an important underlying mechanism of action of aspirin as an anticancer agent and, based on the rapid metabolism of aspirin to salicylate in humans and the high salicylate/aspirin ratios in serum, it is likely that the anticancer activity of aspirin is also due to the salicylate metabolite.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136 · cited 3×
“Aspirin and other NSAIDs reduce the incidence and increase survival of colon cancer patients and similar results have been observed for aspirin as a chemotherapeutic agent for treatment of breast cancer patients [4–8].”
BackgroundResultAspirin Use and Survival After Diagnosis of Colorectal Cancer
Chan, A. T. (2009) · JAMA · doi:10.1001/jama.2009.1112 · Cited by 557 · cited 3×
“Other drugs including NSAIDs such as tolfenamic acid and COX-2 inhibitors also inhibit cancer cell growth and downregulate Sp transcription factors [18–26] and, in this study, we have investigated the effects of aspirin on Sp proteins and other Sp-regulated genes including b-catenin.”
BackgroundInfluentialAspirin Intake and Survival After Breast Cancer
Holmes, M. D., Chen, W. Y., Li, L., Hertzmark, E., Spiegelman, D., & Hankinson, S. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7918 · Cited by 365 · cited 3×
“Aspirin and other NSAIDs reduce the incidence and increase survival of colon cancer patients and similar results have been observed for aspirin as a chemotherapeutic agent for treatment of breast cancer patients [4–8].”
BackgroundResultA Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer Incidence
Jacobs, E. J., Thun, M. J., Bain, E. B., Rodriguez, C., Henley, S. J., & Calle, E. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk132 · Cited by 322 · cited 2×
“Aspirin and other NSAIDs reduce the incidence and increase survival of colon cancer patients and similar results have been observed for aspirin as a chemotherapeutic agent for treatment of breast cancer patients [4–8].”
BackgroundResultChintharlapalli, S., Papineni, S., Ramaiah, S. K., & Safe, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3735 · Cited by 297 · cited 1×
“Moreover, several anticancer agents including NSAIDs and GT-094 (a NO-NSAID), curcumin, betulinic acid and synthetic triterpenoids, and arsenic trioxide decrease expression of Sp1, Sp3, Sp4 and Sp-regulated genes in cancer cells and these effects contribute to their anticancer activity [17,18,20,35].”
BackgroundSelf-citationEffect of aspirin and NSAIDs on risk and survival from colorectal cancer
Din, F. V. N., Theodoratou, E., Farrington, S. M., Tenesa, A., Barnetson, R. A., Cetnarskyj, R., Stark, L., Porteous, M. E., Campbell, H., & Dunlop, M. G. (2010) · Gut · doi:10.1136/gut.2009.203000 · Cited by 284 · cited 1×
“A recent report on the chemopreventive effects of aspirin showed that the incidence of colon cancer in Scotland was significantly decreased in the general population at the lowest daily dose of aspirin (75 mg) and the decreased incidence was observed even after only 5 yr of aspirin use [7].”
BackgroundAspirin, salicylates, and cancer
Elwood, P. C., Gallagher, A. M., Duthie, G. G., Mur, L. A., & Morgan, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60243-9 · Cited by 282 · cited 4×
“Based on the similar effects of aspirin and salicylate as anticancer agents observed in Figures 1, 2, 3 and other studies [3,10,11,40] and the high serum salicylate/aspirin ratios [27], the cancer chemotherapeutic effects of aspirin observed in human cancer studies [3–5,7,8] may primarily be due to the salicylate meta…”
BackgroundResultInfluentialAbdelrahim, M., Smith, R., Burghardt, R., & Safe, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0713 · Cited by 199 · cited 2×
“RNA interference studies in several cancer cell lines show that knockdown of Sp1, Sp3 and Sp4 (singly or in combination) results in decreased expression of growth promoting (EGFR, c-MET, cyclin D1), survival (bcl-2, survivin), angiogenic (VEGF and its receptors), and pro-inflammatory [p65 (NFkB)] genes or gene product…”
BackgroundSelf-citationJutooru, I., Chadalapaka, G., Lei, P., & Safe, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095240 · Cited by 178 · cited 8×
“Previous studies by RNA interference (RNAi) show that both survivin and bcl-2 are regulated by Sp1, Sp3 and Sp4 in cancer cells [17,22,24–26].”
BackgroundResultInfluentialSelf-citationTolfenamic Acid and Pancreatic Cancer Growth, Angiogenesis, and Sp Protein Degradation
Abdelrahim, M., Baker, C. H., Abbruzzese, J. L., & Safe, S. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj232 · Cited by 174 · cited 1×
“Moreover, several anticancer agents including NSAIDs and GT-094 (a NO-NSAID), curcumin, betulinic acid and synthetic triterpenoids, and arsenic trioxide decrease expression of Sp1, Sp3, Sp4 and Sp-regulated genes in cancer cells and these effects contribute to their anticancer activity [17,18,20,35].”
BackgroundSelf-citation
Cited by
Sp1 and the ‘hallmarks of cancer’
Beishline, K., & Azizkhan‐Clifford, J. (2015) · The FEBS Journal · doi:10.1111/febs.13148 · Cited by 524
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Vizcaíno, C., Mansilla, S., & Portugal, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.008 · Cited by 377
Molecular targets of aspirin and cancer prevention
Alfonso, L., Ai, G., Spitale, R. C., & Bhat, G. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.271 · Cited by 222
Plano, D., Karelia, D. N., Pandey, M. K., Spallholz, J. E., Amin, S., & Sharma, A. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01503 · Cited by 186
FOXG1 promotes aging inner ear hair cell survival through activation of the autophagy pathway
He, Z., Li, M., Fang, Q., Liao, F.-L., Zou, S., Wu, X., Sun, H., Zhao, X., Hu, Y., Xu, X., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1916194 · Cited by 157
Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?
Keshavarz, M., Xie, K., Schaaf, K., Bano, D., & Ehninger, D. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01680-x · Cited by 118
Phytotherapeutics in cancer invasion and metastasis
Salehi, B., Zucca, P., Sharifi‐Rad, M., Pezzani, R., Rajabi, S., Setzer, W. N., Varoni, E. M., Iriti, M., Kobarfard, F., & Sharifi‐Rad, J. (2018) · Phytotherapy Research · doi:10.1002/ptr.6087 · Cited by 134
“For example, acetylsalicylic acid induced apoptosis and decreased colon cancer cell growth and inhibited tumor growth in an athymic nude mouse xenograft model acting on the downregulation of Sp1, Sp3, and Sp4 proteins and decreased expression of Sp‐regulated products such as bcl‐2, survivin, VEGF, VEGFR1, cyclin D1, c…”
BackgroundAnti-tumor activity of non-steroidal anti-inflammatory drugs: Cyclooxygenase-independent targets
Liggett, J. L., Zhang, X., Eling, T. E., & Baek, S. J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.021 · Cited by 124
“Aspirin and sodium salicylate have also recently been shown to decrease Sp1, Sp3, and Sp4 in a caspase-dependent manner in human CRC cells in vitro as well as in a mouse model [42].”
BackgroundSpecificity Protein Transcription Factors and Cancer: Opportunities for Drug Development
Safe, S. H., Abbruzzese, J. L., Abdelrahim, M., & Hedrick, E. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0407 · Cited by 127
“Other NSAIDs including aspirin and salicylate, and a nitro NSAID (GT-094) also downregulate Sp1, Sp3, Sp4, and Sp-regulated genes in colon cancer cells, suggesting that this pathway contributes to the anticancer activity of aspirin (17, 69).”
BackgroundSelf-citationSP and KLF Transcription Factors in Digestive Physiology and Diseases
Kim, C.-K., He, P., Bialkowska, A. B., & Yang, V. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.035 · Cited by 115
Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target
Safe, S. H., Imanirad, P., Sreevalsan, S., Nair, V., & Jutooru, I. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.914173 · Cited by 118
“Aspirin induces caspasedependent degradation of Sp1, Sp3 and Sp4 in colon cancer cell lines, and this response can be inhibited in cells co-treated with zinc sulfate [73].”
BackgroundResultInfluentialSelf-citationSingco, B., Liu, L.-H., Chen, Y.-T., Shih, Y.-H., Huang, H., & Lin, C. (2015) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2015.08.017 · Cited by 103
Hedrick, E., Cheng, Y., Jin, U.-H., Kim, K., & Safe, S. H. (2016) · Oncotarget · doi:10.18632/oncotarget.7925 · Cited by 107
Self-citationUnderstanding the Role of the Transcription Factor Sp1 in Ovarian Cancer: from Theory to Practice
Vellingiri, B., Iyer, M., Subramaniam, M. D., Jayaramayya, K., Siama, Z., Giridharan, B., Narayanasamy, A., Dayem, A. A., & Cho, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031153 · Cited by 97
Yue, W., Zheng, X., Lin, Y., Yang, C. S., Xu, Q., Carpizo, D. R., Huang, H., DiPaola, R. S., & Tan, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4126 · Cited by 103
“Both metformin and aspirin can induce apoptosis in different cancer cells, including pancreatic cancer cells [9, 35-43].”
Wang, J., Zhang, C., Zhang, J., He, Y., Lee, Y. M., Chen, S., Lim, T. K., Ng, S., Shen, H., & Lin, Q. (2015) · Scientific Reports · doi:10.1038/srep07896 · Cited by 98
Natural Products as Mechanism‐based Anticancer Agents: Sp Transcription Factors as Targets
Safe, S. H., & Kasiappan, R. (2016) · Phytotherapy Research · doi:10.1002/ptr.5669 · Cited by 95
“In addition, some non-steroidal antiinflammatory drugs also induce caspase-dependent degradation of Sp proteins (Pathi et al., 2012; Pathi et al., 2014), and it is conceivable that some natural product anticancer agents may also activate this pathway.”
BackgroundSelf-citationMaity, G., De, A., Das, A. K., Banerjee, S., Sarkar, S., & Banerjee, S. K. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.49 · Cited by 93
Bateman, L. A., Zaro, B. W., Miller, S. M., & Pratt, M. R. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408322b · Cited by 95
Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
Brennan, C. A., Nakatsu, G., Gallini, C. A., Drew, D. A., Glickman, J. N., Schoen, R. E., Chan, A. T., & Garrett, W. S. (2021) · mBio · doi:10.1128/mbio.00547-21 · Cited by 87
Dachineni, R., Ai, G., Kumar, D. R., Sadhu, S. S., Tummala, H., & Bhat, G. J. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0360 · Cited by 85
“5 mmol/L to 10mmol/L, induced a profound reduction in cell proliferation in HT-29 and other cancer cells (20, 41, 42), but a comparison at lower concentrations was not reported.”
InfluentialSankaranarayanan, R., Kumar, D. R., Altinoz, M. A., & Bhat, G. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239018 · Cited by 79
“Another study showed that aspirin’s ability to inhibit colon cancer cell growth (between 5 and 10 mM) may involve downregulation of specificity protein transcription factors [85].”
BackgroundMolecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs)
Dwivedi, A. K., Gurjar, V., Kumar, S., & Singh, N. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.03.004 · Cited by 61
Liu, Y., Feng, J., Sun, M., Liu, B., Yang, G., Bu, Y., Zhao, M., Wang, T., Zhang, W., Yuan, H.-F., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0014-x · Cited by 71
Fajardo, A. M., & Piazza, G. A. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00101.2014 · Cited by 70
“Aspirin and its major metabolite, sodium salicylate, inhibit the expression of Sp1, Sp3, and Sp4 through caspase-dependent proteolysis in colon cancer cells (88).”
BackgroundSpecificity protein 1: Its role in colorectal cancer progression and metastasis
Bajpai, R., & Nagaraju, G. P. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.024 · Cited by 74
Metformin-induced anticancer activities: recent insights
Safe, S., Nair, V., & Karki, K. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0271 · Cited by 63
“…et al., 2007, 2011; Chadalapaka et al., 2008, 2012, 2013; Jutooru et al., 2010a,b,c, 2014; Basha et al., 2011; Gandhy et al., 2012; Liu et al., 2012; Pathi et al., 2012, 2014, 2011a,b; Sreevalsan and Safe, 2013; Hedrick et al., 2015, 2017; Kasiappan et al., 2016; Safe and Kasiappan, 2016;…”
Self-citationBeyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer
Zhang, X., Feng, Y., Liu, X., Ma, J., Li, Y., Wang, T., & Li, X. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02902-6 · Cited by 60
Navy Beans Impact the Stool Metabolome and Metabolic Pathways for Colon Health in Cancer Survivors
Baxter, B. A., Oppel, R. C., & Ryan, E. P. (2018) · Nutrients · doi:10.3390/nu11010028 · Cited by 57
“Salicylate occurs naturally in many plants and has numerous evidences for being highly effective for treating colon cancer patients post diagnosis [69].”
BackgroundSpecificity Proteins (Sp) and Cancer
Safe, S. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065164 · Cited by 60
Self-citationRalph, S. J., Pritchard, R., Rodríguez‐Enríquez, S., Moreno‐Sánchez, R., & Ralph, R. K. (2015) · Pharmaceuticals · doi:10.3390/ph8010062 · Cited by 57
“Aspirin (200 mg/kg/day) decreased RKO colon cancer cell growth and induced apoptosis [117].”
BackgroundThe Influence of In Vitro Gastrointestinal Digestion on the Anticancer Activity of Manuka Honey
Cianciosi, D., Forbes-Hernández, T. Y., Afrin, S., Gasparrini, M., Quiles, J. L., Gil‐Martín, E., Bompadre, S., Simal‐Gándara, J., Battino, M. A., & Giampieri, F. (2020) · Antioxidants · doi:10.3390/antiox9010064 · Cited by 54
“Meanwhile, there are studies that evaluated the apoptotic effect of some single compounds also found in MH and DMH, and pinocembrin, the flavonoid mostly present in MH with the greatest loss after the process of in vitro digestion, exerts a particularly elevated proapoptotic effect on HCT-116, promoting Bax translocat…”
BackgroundLi, X., Pathi, S. S., & Safe, S. H. (2015) · BMC Cancer · doi:10.1186/s12885-015-1956-8 · Cited by 52
“Thus, sulindac sulfide was the most active sulindac derivative as observed in previous studies [33, 34] and the results suggest that the growth inhibitory effects of sulindac sulfide are correlated with downregulation of pro-oncogenic Sp proteins, and previous studies show that knockdown of one or more [35, 36] Sp pro…”
BackgroundResultSelf-citationTewari, D., Majumder, D., Vallabhaneni, S., & Bera, A. K. (2017) · Scientific Reports · doi:10.1038/srep45184 · Cited by 54
Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas
Dilwali, S., Kao, S., Fujita, T., Landegger, L. D., & Stanković, K. M. (2015) · Translational research · doi:10.1016/j.trsl.2014.12.007 · Cited by 47
Asif, M., Shafaei, A., Jafari, S. F., Mohamed, S. K., Ezzat, M. O., Majid, A. S. A., Oon, C. E., Petersen, S. H., Kono, K., & Majid, A. M. S. A. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.05.027 · Cited by 47
Ai, G., Dachineni, R., Muley, P., Tummala, H., & Bhat, G. J. (2015) · Tumor Biology · doi:10.1007/s13277-015-3959-0 · Cited by 57
Deng, R., Wu, H., Ran, H., Kong, X., Hu, L., Wang, X., & Su, Q. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.02.024 · Cited by 42
Navone, S. E., Guarnaccia, L., Cordiglieri, C., Crisà, F. M., Caroli, M., Locatelli, M., Schisano, L., Rampini, P. M., Miozzo, M. R., Verde, N. M. L., et al. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.08.080 · Cited by 41
Ai, G., Dachineni, R., Kumar, D. R., Marimuthu, S., Alfonso, L. F., & Bhat, G. J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4438-3 · Cited by 41
The role of aspirin in preventing colorectal cancer
Burn, J., & Sheth, H. J. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw028 · Cited by 41
Uddin, M. N., Li, M., & Wang, X. (2019) · Cells · doi:10.3390/cells8091054 · Cited by 42
“SP1 and SP4 are essential for colon cancer cells and knockdown of them may induce apoptosis in cancer cells [52].”
BackgroundLiu, C., Rokavec, M., Huang, Z., & Hermeking, H. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06226-9 · Cited by 42
Guo, L., Yuan, J., Xie, N., Wu, H., Chen, W., Song, S., & Wang, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5645 · Cited by 35
“It has been found to be upregulated in several types of cancer, including breast cancer (30), gastric cancer (31), hepatocellular carcinoma (32), thyroid cancer (33), colorectal cancer (34), pancreatic cancer (35) and lung cancer (36).”
Sreevalsan, S., & Safe, S. H. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0486 · Cited by 34
“iSp1 also decreased expression of Sp4 as previously reported, indicating that Sp4 is an Sp1-regulated gene in SW480 cells (43).”
BackgroundSelf-citationNucleolin enhances internal ribosomal entry site (IRES)-mediated translation of Sp1 in tumorigenesis
Hung, C.-Y., Yang, W., Wang, S., Hsu, T., Chang, W., & Hung, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.08.009 · Cited by 31
Benjamin, D. J., Haslam, A., & Prasad, V. (2024) · Cancer Medicine · doi:10.1002/cam4.7049 · Cited by 30
“11,16 At the same time, repurposed drugs rarely demonstrate RECIST (Response Evaluation Criteria in Solid Tumors) 1.1 tumor responses (30”
BackgroundInfluentialPlatelets and (Lymph)angiogenesis
Roweth, H. G., & Battinelli, E. M. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041174 · Cited by 32
Wu, D., Niu, X., PAN, H., Zhou, Y., Zhang, Z., Qü, P., & Zhou, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.4953 · Cited by 29
“Sp1 has been identified to be upregulated in various types of human cancer, including breast carcinoma (41), thyroid cancer (42), hepatocellular carcinoma (43), pancreatic cancer (44), colorectal cancer (45), gastric cancer (46) and lung cancer (47).”
Andrews, P. C., Blair, V. L., Ferrero, R. L., Junk, . C., & Kumar, I. (2013) · Chemical Communications · doi:10.1039/c3cc40645h · Cited by 30
Li, X., Zhu, Y., He, H., Lou, L., Ye, W., Chen, Y., & Wang, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.088 · Cited by 29
Astragaloside IV protects rat gastric mucosa against aspirin-induced damage
Fan, D., Lin, S., Song, Y., Wang, Z.-Y., Liu, B., Gao, S., Fan, Y., Zhu, S. L., Li, S., & Jiang, L. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.10.018 · Cited by 30
Shi, T., Fujita, K., Gong, J., Nakahara, M., Iwama, H., Liu, S., Yoneyama, H., Morishita, A., Nomura, T., Tani, J., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7630 · Cited by 28
“activity in vitro and in vivo (18,19), although in this study we specifically researched only the aspirin concentration.”
BackgroundCelecoxib promotes degranulation of CD8+ T cells in HPV-induced lesions of K14-HPV16 transgenic mice
dos Santos, C. E. M., Neto, T., Ferreirinha, P., de Sousa, H. M. L., Ribeiro, J., Bastos, M. M. S. M., Faustino‐Rocha, A. I., Oliveira, P. A., Medeiros, R., Vilanova, M., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.05.040 · Cited by 27
“Some non-steroidal anti-inflammatory drugs, like aspirin and ibuprofen, have already shown promising results as anti-tumour therapy in both patients and pre-clinical animal models [38-41].”
BackgroundLi, C.-H., Zhou, Y., Tu, P., Zeng, K., & Jiang, Y. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106178 · Cited by 26
Farrugia, G., & Balzan, R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/504230 · Cited by 28
“Further studies have since shown that aspirin-mediated downregulation of Wnt/β-catenin/TCF signalling can indeed be mediated by its induced inactivation of protein phosphatase 2A [148] but also, in part, by the downregulation of upstream specificity protein (Sp) transcription factors [149].”
BackgroundAspirin-inspired organometallic compounds: Structural characterization and cytotoxicity
Ashraf, A., Hanif, M., Kubanik, M., Söhnel, T., Jamieson, S. M. F., Bhattacharyya, A., & Hartinger, C. G. (2017) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2017.01.016 · Cited by 27
Fernandez, H. R., & Lindén, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-06149-4 · Cited by 26
Pozzoli, G., Marei, H. E. S., Al-Thani, A., Boninsegna, A., Casalbore, P., Marlier, L. N. J. L., Lanzilli, G., Zonfrillo, M., Petrucci, G., Rocca, B., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28194 · Cited by 26
“…properties (Hua, Zhang, Kong, Wang, & Jiang, 2018) including induction of apoptosis and chemotherapeutics sensibility, inhibition of proliferation, and metastasis (Z. Chen, Li, et al., 2018; Kim et al., 2009; McCarty & Block, 2006; Pathi et al., 2012; X. Zhang, Feng, Li, Guo, & Li, 2018).”
BackgroundNitric oxide donor hybrid compounds as promising anticancer agents
Ding, Q., Zang, J., Gao, S., Gao, Q., Duan, W., Li, X., Xu, W., & Zhang, Y. (2016) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2016.01067 · Cited by 25
“Aspir in (ASA), a kind of non-steroidal ant i inflammatory drug (NSAIDs), showed potency in inhibiting colorectal cancer (38).”
BackgroundBaicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor
Ma, W., Liu, X., & Du, W. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000708 · Cited by 25
Systems biology‐embedded target validation: improving efficacy in drug discovery
Vandamme, D., Minke, B., Fitzmaurice, W., Kholodenko, B. Ν., & Kölch, W. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1253 · Cited by 25
“Even for some of the most common drugs such as aspirin, we still lack knowledge on their full effects.(3) Developments in the fields of signalling networks, robotics, high-throughput arrays and the human genome project have transferred drug discovery away from this phenomenological process towards a more targeted appr…”
BackgroundZhang, H., Lu, J., Jiao, Y., Chen, Q., Li, M., Wang, Z., Yu, Z., Huang, X., Yao, A., Gao, Q., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00679 · Cited by 25
“On the other hand, other reports have shown that aspirin inhibits tumor growth through direct downregulation of Sp1 in colon cancer cells (33); this discrepancy may be due to different”
BackgroundMutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
Turturro, S. B., Najor, M. S., Ruby, C. E., Cobleigh, M., & Abukhdeir, A. M. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3729-8 · Cited by 25
“In this study, we set out to determine if mutations in PIK3CA sensitized breast cancer cells to physiologic doses of aspirin, as determined by the range of basal serum aspirin levels previously described [28, 29].”
BackgroundHaldar, R., Berger, L. S., Rosenne, E., Radin, A. S., Eckerling, A., Sandbank, E., Sloan, E. K., Cole, S. W., & Ben‐Eliyahu, S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.005 · Cited by 23
Ying, J., Yu, X., Ma, C., Zhang, Y., & Dong, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6759 · Cited by 22
“Overexpression of SP1 has been frequently observed in melanoma, breast cancer (34), HCC (35), colon cancer (36), pancreatic cancer (37), gastric cancer (38) and prostate cancer (39,40).”
BackgroundRetractedBioactive lipid metabolism in platelet “first responder” and cancer biology
Marie, P. K., Kopetz, S., Hawk, E. T., Millward, S. W., Sood, A. K., Gresele, P., Overman, M. J., Honn, K. V., & Menter, D. G. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9755-8 · Cited by 23
Prediction of key regulators and downstream targets of E. coli induced mastitis
Sharifi, S., Pakdel, A., Ebrahimie, E., Aryan, Y., Ghaderi‐Zefrehei, M., & Reecy, J. M. (2019) · Journal of Applied Genetics · doi:10.1007/s13353-019-00499-7 · Cited by 22
Lee, R. H., Jeon, Y., Cho, J. H., Jang, J.-Y., Kong, I., Kim, S., Kim, M. S., Chung, H., Oh, K. B., Park, S., et al. (2017) · General Physiology and Biophysics · doi:10.4149/gpb_2016024 · Cited by 21
“Furthermore, Sp1 is often over-expressed in several types of cancer cells, such as in gastric, thyroid, lung, and colorectal cancers, but not in normal cells (Chiefari et al. 2002; Wang et al. 2003; Chuang et al. 2009; Colon et al. 2011; Pathi et al. 2012).”
BackgroundInfluence of Pain and Analgesia on Cancer Research Studies
Taylor, D. K. (2019) · Comparative Medicine · doi:10.30802/aalas-cm-19-000002 · Cited by 23
Taoka, R., Jinesh, G. G., Xue, W., Safe, S. H., & Kamat, A. M. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1359-1 · Cited by 19
Self-citationTGF‑β1 mediates the effects of aspirin on colonic tumor cell proliferation and apoptosis
Wang, Y., Du, C., Zhang, N., Li, M., Liu, Y., Zhao, M., Wang, F., & Luo, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.8047 · Cited by 19
“TGF-β1 is also an inhibitor of tumor growth that is capable of inducing apoptosis in various types of cancer cells; however, the reaction of diverse malignant cells to TGF-β1 is different: During the process of cancer development, certain transformed cells become partly or completely resistant to TGF-β1 growth inhibit…”
Lee, Y. R., Park, M. S., Joo, H. K., Kim, K. M., Kim, J. R., Jeon, B. H., & Choi, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-27025-9 · Cited by 19
Quercetin’s Dual Mode of Action to Counteract the Sp1-miR-27a Axis in Colorectal Cancer Cells
Fosso, E., Leo, M., Muccillo, L., Mandrone, V. M., Meo, M. C. D., Molinario, A., Varricchio, E., & Sabatino, L. (2023) · Antioxidants · doi:10.3390/antiox12081547 · Cited by 20
Esfahani, A. T., Mohammadpour, S., Jalali, P., Yaghoobi, A., Karimpour, R., Torkamani, S. S., Pardakhtchi, A., Salehi, Z., & Mojarad, E. N. (2024) · Scientific Reports · doi:10.1038/s41598-024-61000-x · Cited by 23
“The other experimentally validated transcription factor, Sp1, is also shown to increase the expression of VEGF-A and VEGFR 66 .”
BackgroundSpampatti, M. P., Vlotides, G., Spöttl, G., Maurer, J., Göke, B., & Auernhammer, C. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.10038 · Cited by 18
Brighenti, E., Giannone, F. A., Fornari, F., Onofrillo, C., Govoni, M., Montanaro, L., Treré, D., & Derenzini, M. (2016) · Oncotarget · doi:10.18632/oncotarget.11441 · Cited by 18
“Most studies on the anti-cancerous effect of aspirin have shown that the drug induced apoptotic death in cancer cells [28–33].”
Aspirin Repurposing in Folate-Decorated Nanoparticles: Another Way to Target Breast Cancer
Kanwal, F., Ma, M., Rehman, M. F. U., Khan, F. U., Elizur, S. E., Batool, A. I., Wang, C. C., Tabassum, T., Lu, C., & Wang, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.788279 · Cited by 18
“The correlation between the regular use of aspirin and reduced risk of cancer suggests its chemopreventive and chemotherapeutic properties (Pathi et al., 2012; Jonsson et al., 2013; Tougeron et al., 2014; Maity et al., 2015; Saha et al., 2016).”
BackgroundAspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances
Laila, U. E., Zhao, Z., Lui, H., & Xu, Z.-X. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s505636 · Cited by 19
“121 Recent studies have also explored combination therapies involving aspirin, such as its pairing with γ-tocopherol (γT) to reduce tumor size and multiplicity in a colitis-associated cancer (CAC) model, while mitigating aspirin-induced gastric lesions and altering the gut microbiota.”
Fe3O4/salicylic acid nanoparticles versatility in magnetic mediated vascular nanoblockage
Mîndrilă, I., Buteică, S. A., Mihăiescu, D. E., Badea, G., Fudulu, A., & Mărgăritescu, D. N. (2016) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-3318-5 · Cited by 17
“Salicylic acid shell was used for its good biocompatibility, being a normal component of serum (Baxter et al. 2002), and because it is associated with decreased risk for colorectal, breast, esophageal, lung, stomach, and ovarian cancer (Pathi et al. 2012).”
BackgroundNi, J., Yang, Y., Liu, D., Sun, H., Jin, S., & Li, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.5869 · Cited by 15
RetractedShimura, T., Toden, S., Komarova, N. L., Boland, C. R., Wodarz, D., & Goel, A. (2020) · Carcinogenesis · doi:10.1093/carcin/bgz195 · Cited by 16
“Although the anti-tumorigenic effect of aspirin has been documented in several in vitro systems, the dose of aspirin utilized in the majority of such studies was often deemed too high (28,37).”
BackgroundZhen, X.-E., Zong, M., Gao, S., Cao, Y., Jiang, L., Chen, S.-X., Wang, K., Sun, S., Peng, H., Bai, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098513 · Cited by 14
“Research has shown that ASP can be used to treat and prevent cancers, such as breast cancer [3], colon cancer [4] and rectal carcinoma [5].”
Xie, B., Zhao, L., Guo, L., Liu, H., Fu, S., Fan, W., Li, L., Chen, J., Wang, B., Fan, L.-L., et al. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10390 · Cited by 18
“as BiTc was reported to phosphorylate β-catenin, decrease β-catenin levels, and downregulate Wnt2, cyclin d1 and c-Myc, it was suggested that BiTc exerted its antitumor properties by regulating the Wnt/β-catenin signaling pathway; however, previous studies indicated that the expression levels of cyclin d1, c-myc and β…”
BackgroundIftode, C., Iurciuc, S., Marcovici, I., Macasoi, I. G., Coricovac, D. E., Dehelean, C. A., Ursoniu, S., Rusu, A., & Ardelean, S. (2024) · Life · doi:10.3390/life14050606 · Cited by 12
“These data represent a novel path for further exploration of the ASA+GEN combination’s therapeutic potential by elucidating their mechanism of action that impacts the carcinogenesis and angiogenesis processes in CRC.”
BackgroundPiazuelo, E., Esquivias, P., Martino, A. D., Cebrián, C., Conde, B., Santander, S., Emperador, S., García-González, M. A., Carrera‐Lasfuentes, P., & Lanas, Á. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4225-z · Cited by 12
Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study
Nounu, A., Richmond, R. C., Stewart, I. D., Surendran, P., Wareham, N. J., Butterworth, A. S., Weinstein, S. J., Albanes, D., Baron, J. A., Hopper, J. L., et al. (2021) · Nutrients · doi:10.3390/nu13114164 · Cited by 12
Qian, M. D., Gong, H., Yang, X., Zhao, J., Yan, W., Lou, Y., Peng, D., Li, Z., & Xiao, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.8268 · Cited by 12
“Previous studies reported that SP1 was increased in multiple types of human cancer, including colon (36), prostate (37,38), pancreatic (24), lung (39) and gastric cancer (40).”
RetractedArango-Varela, S. S., Luzardo‐Ocampo, I., Reyes‐Dieck, C., Yahia, E. M., & Celis, M. E. M. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13760 · Cited by 11
Șușan, M. M., Macasoi, I. G., Pînzaru, I., Dehelean, C. A., Ilia, I., Șușan, R. M., & Ioniță, I. (2023) · Current Oncology · doi:10.3390/curroncol30070460 · Cited by 12
The effects of aspirin plus cisplatin on SGC7901/CDDP cells in vitro
Dong, H., LIU, G., Jiang, B., Guo, J., Tao, G., YIU, W., Zhou, J., & Li, G. (2014) · Biomedical Reports · doi:10.3892/br.2014.241 · Cited by 11
“Pathi et al (20) also suggested that the anticancer activity of aspirin may be due to its salicylate metabolite.”
BackgroundSperanza, F., Mahankali, M., & Gómez-Cambronero, J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313174 · Cited by 10
“PA produced by PLD is a factor in the activation of -catenin [33], which has been shown to be regulated by certain Sp proteins [39].”
BackgroundCheng, Y., Lin, J., Liu, J., Wang, Y., Yan, W., & Zhang, M. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000409 · Cited by 10
“Previous literature has also reported that aspirin at therapeutic doses is able to inhibit VEGF expression in multiple cell lines.(26,27) Therefore, it is reasonable to assume that FIGURE 3.”
BackgroundKing, N. A., Lawton, C. R., Delargy, H. J., Smith, F., & Blundell, J. E. (1997) · QUT ePrints (Queensland University of Technology) · Cited by 10
Chen, J., Chu, Z., Zhang, Q., Wang, C., Luo, P., Zhang, Y., Xia, F., Gu, L., Wong, Y., Shi, Q., et al. (2024) · Chemical Science · doi:10.1039/d3sc04826h · Cited by 10
Safi, R., Mohsen‐Kanson, T., Nemer, G. M., Dekmak, B., Rubeiz, N., El-Sabban, M. E., Nassar, D., Eid, A. A., Abbas, O. M., Kibbi, A., et al. (2019) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2019.03.09 · Cited by 9
“For instance, medications composed of acetylsalicylic acid such as aspirin, have been shown to be protective in different cancers including colon cancer, prostate cancer and bladder cancer (12,13).”
BackgroundFadilah, F., Andrajati, R., Arsianti, A., Paramita, R. I., Erlina, L., Istiadi, K. A., & Yanuar, A. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.9.2973 · Cited by 9
“Salicylic acid is used as a colorectal anticancer that can induce apoptosis and reduce the growth of SW480 colon cancer, HT-29 and HCT-116 (Pathi et al., 2012).”
BackgroundLü, B., Hu, S., Wu, C., Zhang, J., Zhang, J., & Zhang, J. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202200277 · Cited by 8
Chen, J., Chen, J., & Li, W. (2016) · Oncology Letters · doi:10.3892/ol.2016.5527 · Cited by 9
Gao, M., Guo, K.-M., Wei, Y.-M., Ma, M.-M., Cai, J., Xia, T., & Ye, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.5915 · Cited by 8
“In addition, in vitro experiments, the effective doses of aspirin in most studies in colon, prostate or breast cancer cells vary from 1-10 mmol/l (26,34,35).”
Background
Metadata
- Authors
- Pathi, S., Jutooru, I., Chadalapaka, G., Nair, V., Lee, S.-O., & Safe, S.
- Affiliations
- Texas A&M University (US)
- Texas A&M Health Science Center (US)
- Corresponding author
- Safe, Stephen
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-26
- Volume
- 7
- Issue
- 10
- Pages
- e48208
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3482208
- OpenAlex
- W1968810018
- Cited by
- 127
- References
- 41
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 10 · 2018: 11 · 2017: 13 · 2016: 16 · 2015: 17 · 2014: 11 · 2013: 9
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- OakTrust (Texas A&M University Libraries) (submittedVersion)
- Funders
- Texas AgriLife Research
- National Institutes of Health
- National Cancer Institute (R01CA136571)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- aspirin, colon cancer, specificity proteins, Sp1, Sp3, Sp4, salicylates, apoptosis, zinc ions, β-catenin, NF-κB, Bcl-2, survivin, vascular endothelial growth factor, c-Met, cyclin D1, tumor growth inhibition, anticancer mechanism
- MeSH terms
- Animals, Aspirin, Colonic Neoplasms, Female, Humans, Mice, Nude, Gene Expression Regulation, Neoplastic, Sp1 Transcription Factor, Xenograft Model Antitumor Assays, Cell Proliferation, Mice, Sp Transcription Factors, Sp3 Transcription Factor, Sp4 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.